Literature DB >> 16917529

Poliovirus vaccine strains in sewage and river water in South Africa.

D N Pavlov1.   

Abstract

Since the initiation of the global poliomyelitis eradication program in 1988, the number of wild-type polio cases decreased from 350,000 to fewer than 500, and the number of polio endemic countries declined from more than 125 to 10. The last case of polio in South Africa caused by a wild-type poliovirus (PV) occurred in 1989. The live attenuated oral poliovirus vaccine (OPV) has been effectively used in the reduction and control of poliomyelitis. However, as OPV strains are excreted in stools after vaccination, this vaccine could become a source of dissemination of PVs in the environment and the potential cause of poliomyelitis. Therefore, the aim of the study was to determine the occurrence of OPV strains in selected sewage and river water samples. During the period between 2001 and 2003, 138 samples of river water and 213 samples of settled sewage were collected from selected areas of South Africa. A total of 860 plaques were analysed, which consisted of 703 plaques from the sewage and 157 plaques from the river water samples. Using a reverse transcriptase (RT)-multiplex PCR, 49 PVs were successfully distinguished from 176 non-polio enteroviruses (NPEVs). The 176 NPEVs consisted of 50 coxsackie B2 viruses (CBV2), followed by 39 echoviruses 11 (ECV11), 25 CBV5, 21 CBV3, 15 CBV4, 14 coxsackie A6 viruses (CAV6), 7 CBV6, 2 CAV5, 2 CBV1, and 1 ECV19, which was in agreement with the prevalence of these EVs in other parts of the world. The Sabin-specific RT-triplex PCR revealed the presence of 29 Sabin PV type 1, 8 Sabin PV type 2, and 12 Sabin PV type 3 isolates. Buffalo green monkey kidney and primary liver carcinoma cell cultures allowed the amplification of a broad spectrum of EVs, whereas human epidermoid carcinoma cells were more selective for PVs. This study addressed some of the issues regarding the prevalence of OPV strains in the environment. The identification of 49 viable OPV isolates confirmed the presence and circulation of PV vaccine strains in sewage and river water. The extent of the potential health risk constituted by these OPV isolates remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16917529     DOI: 10.1139/w06-026

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  5 in total

1.  Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks.

Authors:  Stephanie B Troy; Leticia Ferreyra-Reyes; Chunhong Huang; Clea Sarnquist; Sergio Canizales-Quintero; Christine Nelson; Renata Báez-Saldaña; Marisa Holubar; Elizabeth Ferreira-Guerrero; Lourdes García-García; Yvonne A Maldonado
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226

Review 2.  Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Authors:  Radboud J Duintjer Tebbens; Marita Zimmermann; Mark A Pallansch; Kimberly M Thompson
Journal:  Food Environ Virol       Date:  2017-07-07       Impact factor: 2.778

3.  Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.

Authors:  Beatriz T Costa-Carvalho; Kathleen E Sullivan; Patrícia M Fontes; Fernanda Aimé-Nobre; Isabela G S Gonzales; Elaine S Lima; Celso Granato; Maria Isabel de Moraes-Pinto
Journal:  J Clin Immunol       Date:  2018-07-14       Impact factor: 8.317

4.  Quantitative RT-PCR detection of hepatitis A virus, rotaviruses and enteroviruses in the Buffalo River and source water dams in the Eastern Cape Province of South Africa.

Authors:  Vincent Nnamdigadi Chigor; Anthony Ifeanyi Okoh
Journal:  Int J Environ Res Public Health       Date:  2012-11-05       Impact factor: 3.390

Review 5.  A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus.

Authors:  Graciela Matrajt; Brienna Naughton; Ananda S Bandyopadhyay; John Scott Meschke
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.